|1.||Zhu, Yan: 3 articles (01/2014 - 05/2007)|
|2.||Cao, Lin: 3 articles (01/2014 - 05/2007)|
|3.||Cao, Yang: 2 articles (01/2014 - 12/2012)|
|4.||La Marca, Antonio: 2 articles (12/2004 - 01/2002)|
|5.||Collins, J: 2 articles (01/2003 - 01/2000)|
|6.||Vandekerckhove, P: 2 articles (01/2003 - 01/2000)|
|7.||Fedorkow, D: 2 articles (01/2003 - 01/2000)|
|8.||Hughes, E: 2 articles (01/2003 - 01/2000)|
|9.||Shen, Lin: 1 article (10/2015)|
|10.||Xiao, Jing: 1 article (10/2015)|
01/31/1987 - "There was a significant difference in improvement of the disease in the gestrinone group compared with placebo (p = 0.004), confirming that gestrinone is an effective treatment of endometriosis. "
08/01/1995 - "The results indicate that gestrinone is effective in the treatment of pelvic endometriosis. "
08/01/1996 - "Gestrinone 2.5 mg given twice a week for six months provides an effective and safe treatment for those women suffering from endometriosis."
01/01/1997 - "The clinical and histological efficacy of gestrinone in the treatment of endometriosis was evaluated. "
08/01/1996 - "The purpose of this open study is to evaluate the efficacy and tolerance of gestrinone in the treatment of endometriosis. "
05/02/1987 - "The relation between asymptomatic endometriosis and infertility was investigated in a randomised double blind placebo controlled trial of the impact of treating the endometriosis with gestrinone. "
01/01/1999 - "The results suggest that gestrinone may be considered an option for the treatment of endometriosis related infertility."
10/01/1992 - "[Gestrinone in the therapy of sterility due to endometriosis]."
05/01/1989 - "The results of this study suggest that gestrinone is as effective as danazol in the treatment of infertility associated with endometriosis and is better tolerated."
11/01/1987 - "A clinicopathologic study of a short-term medical treatment of endometriosis with danazol or gestrinone was performed in 50 patients with endometriosis and infertility. "
01/25/1992 - "The gestrinone group had significantly greater reductions than the placebo group in breast pain score at months 1, 2, and 3 of treatment (mean reduction 59.5 [SD 22.6] to 11.7 [17.0] vs 58.2 [17.6] to 36.7 [23.0] at month 3; p less than 0.0001). "
01/25/1992 - "Multicentre study of gestrinone in cyclical breast pain."
12/01/1996 - "A tendency to prolonged pain reduction was observed after gestrinone compared with LA treatment. "
12/01/1996 - "Moderate or severe pain symptoms recurrence on both pain scales was observed in 2 of 17 (11.8%) patients given gestrinone compared with 9 of 17 (52.9%) of those given LA (odds ratio, 0.12; 95% confidence interval, 0.02 to 0.69). "
02/29/1992 - "Gestrinone in cyclical breast pain."
05/01/2015 - "Gestrinone combined with ultrasound-guided aspiration and ethanol injection therapy is an effective treatment for ovarian chocolate cyst with low recurrence rate."
05/01/2015 - "The aim of this study was to determine clinical performance of gestrinone combined with ultrasound-guided aspiration and ethanol injection in treating chocolate cyst of ovary. "
05/01/2015 - "Gestrinone combined with ultrasound-guided aspiration and ethanol injection for treatment of chocolate cyst of ovary."
04/01/1988 - "4) Chocolate cyst size became smaller in 60.0% of the Gestrinone group and 77.8% of the Danazol group. "
12/01/1996 - "To evaluate the efficacy of gestrinone versus leuprolide acetate (LA) in improving pelvic pain in women with endometriosis and to compare their effects on bone mineral density and serum lipid profile. "
12/01/1996 - "Gestrinone versus a gonadotropin-releasing hormone agonist for the treatment of pelvic pain associated with endometriosis: a multicenter, randomized, double-blind study. "
|3.||Gonadotropin-Releasing Hormone (GnRH)
|4.||Ethanol (Ethyl Alcohol)
|5.||Medroxyprogesterone Acetate (Depo-Provera)
|7.||Steroid Receptors (Steroid Receptor)
|4.||Intrauterine Devices (Intrauterine Device)
|5.||Contraception (Birth Control)